Axon guidance molecules in immunometabolic diseases
Abstract The global prevalence of metabolic diseases, such as obesity, diabetes, and atherosclerosis, is rapidly increasing and has now reached epidemic proportions. Chronic tissue inflammation is a characteristic of these metabolic diseases, indicating that immune responses are closely involved in...
Main Authors: | Yoshimitsu Nakanishi, Sujin Kang, Atsushi Kumanogoh |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-01-01
|
Series: | Inflammation and Regeneration |
Subjects: | |
Online Access: | https://doi.org/10.1186/s41232-021-00189-0 |
Similar Items
-
Semaphorins in Angiogenesis and Autoimmune Diseases: Therapeutic Targets?
by: Vijaya Iragavarapu-Charyulu, et al.
Published: (2020-03-01) -
SEMAPHORINS and their receptors: focus on the crosstalk between melanoma and hypoxia
by: Elisabetta Valentini, et al.
Published: (2021-04-01) -
Axon Guidance Molecules and Pain
by: Elisa Damo, et al.
Published: (2022-10-01) -
A SEMA3 Signaling Pathway-Based Multi-Biomarker for Prediction of Glioma Patient Survival
by: Indre Valiulyte, et al.
Published: (2020-10-01) -
Semaphorin signaling in vertebrate neural circuit assembly
by: Yutaka eYoshida
Published: (2012-06-01)